Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 14, 2012 07:02 ET | Source: Photocure ASA

Photocure ASA : Invitasjon til presentasjon av 4. kvartal og 2011 resultater

Photocure ASA presenterer selskapets resultater for 4. kvartal 2011/ årsresultat 2011 torsdag 16. februar 2012 på Shippingklubben, Haakon VIIs gate 1 (øverste etasje), Oslo. Presentasjonen starter...
February 14, 2012 07:02 ET | Source: Photocure ASA

Photocure ASA : Presentation of the fourth quarter and full year 2011 report

Photocure will present its fourth quarter and full year 2011 report on Thursday 16th of February 2012 at Shippingklubben, Haakon VIIs gate 1 (top floor), Oslo, Norway. The presentation will begin at...
February 02, 2012 02:15 ET | Source: Photocure ASA

Photocure ASA - Photocure's partner Ipsen offentliggjør 4Q11 Hexvix® salg i Tyskland og Italia

PHOTOCURES PARTNER IPSEN OFFENTLIGGJØR 4Q11 HEXVIX® SALG I TYSKLAND OG ITALIA Oslo, 2. februar 2012. Photocure ASA (OSE: PHO), et farmasøytisk selskap som spesialiserer seg innen fotodynamisk...
February 02, 2012 02:15 ET | Source: Photocure ASA

Photocure ASA - Photocure's partner Ipsen announces 4Q11 Hexvix® sales in Germany and Italy

PHOTOCURE'S PARTNER IPSEN ANNOUNCES 4Q 11 HEXVIX® SALES IN GERMANY AND ITALY Oslo, Norway, February 2, 2012: Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic...
January 13, 2012 02:00 ET | Source: Photocure ASA

Photocure ASA - Photocure announces completion of Visonac® study enrolment

PHOTOCURE ANNOUNCES COMPLETION OF VISONAC® STUDY ENROLMENT Novel photodynamic therapeutic treatment for acne Oslo, Norway, January 13, 2012: Photocure ASA (OSE: PHO), a specialty pharmaceutical...
January 13, 2012 02:00 ET | Source: Photocure ASA

Photocure ASA - Pasientinklusjon for Visonac® studie ferdig

PHOTOCURE - PASIENTINKLUSJON FOR VISONAC® STUDIE FERDIG Første fotodynamiske behandlingsalternativ for kviser Oslo, Norge, 13. januar 2012: Photocure ASA (OSE: PHO), et farmasøytisk selskap...
January 09, 2012 02:00 ET | Source: Photocure ASA

Photocure ASA - Photocure styrker Ledergruppen

PHOTOCURE STYRKER LEDERGRUPPEN Oslo, Norge, 9. januar 2012: Photocure ASA (OSE: PHO), et farmasøytisk selskap som spesialiserer seg innen fotodynamisk teknologi for dermatologi og kreft,...
January 09, 2012 02:00 ET | Source: Photocure ASA

Photocure ASA - Photocure strengthens the Management Team

PHOTOCURE STRENGTHENS THE MANAGEMENT TEAM Oslo, Norway, January 9, 2012: Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in dermatology and...
January 03, 2012 02:00 ET | Source: Photocure ASA

Photocure ASA - Pasientinklusjon i Cevira studie ferdig

Pasientinklusjon i Cevira studie ferdig Første studie som evaluerer optimal behandlingsdose for ny integrert prosedyre. Første mulige behandlingsalternativ for vedvarende human papillomavirus...
January 03, 2012 02:00 ET | Source: Photocure ASA

Photocure ASA - Cevira Study completes study enrolment on time

Cevira study completes study enrolment on time First study to evaluate optimal dose of novel integrated drug-delivery device. First novel therapeutic treatment option for highly prevalent cervical...